Clune & Associates’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$995K Sell
7,771
-371
-5% -$45.7K 0.15% 83
2026
Q1
$905K Sell
8,142
-2,962
-27% -$339K 0.17% 93
2025
Q4
$1.24M Buy
11,104
+9,021
+433% +$994K 0.27% 79
2025
Q3
$226K Buy
2,083
+3
+0.1% +$315 0.06% 147
2025
Q2
$210K Buy
+2,080
New +$195K 0.06% 148
2025
Q1
Sell
-2,131
Closed -$207K 143
2024
Q4
$207K Buy
+2,131
New +$209K 0.07% 133

Other funds holding AVUS

Clune & Associates's AVUS Position: Q2 2026 in Review

Clune & Associates reduced its Avantis US Equity ETF (AVUS) stake by 4.6% in Q2 2026, selling an estimated $45.7K and leaving 7,771 shares worth $995K. The position accounts for 0.15% of the portfolio, ranked #83.

Clune & Associates first reported a position in AVUS in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.24M in Q4 2025. 146 funds tracked by Wall St. Rank hold AVUS as of Q2 2026.

  • Clune & Associates held 7,771 shares of Avantis US Equity ETF worth $995K as of Q2 2026.
  • Clune & Associates sold 371 Avantis US Equity ETF shares in Q2 2026, an estimated $45.7K.
  • Avantis US Equity ETF made up 0.15% of Clune & Associates's portfolio in Q2 2026, its #83 holding.
  • Clune & Associates first reported a position in Avantis US Equity ETF in Q4 2024 and has held it in 6 quarters since.
  • Clune & Associates's Avantis US Equity ETF position peaked at $1.24M in Q4 2025.
  • 146 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q2 2026.

Based on Clune & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.